Teams at each of New York City's leading universities are making important research advances. Their overarching goal is to understand the molecular underpinnings of disease and then rapidly translate the information to the clinic. Using a combination of advanced imaging technologies, biophotonics, immunology, translational research and other areas of basic science, they work to achieve this goal.
Although the building itself is still under construction, New York University School of Medicine's Smilow Biomedical Research Center already sees itself as an integral part of New York's medical and research community, according to Vicki Match-Suna, associate dean and vice president of real estate and strategic capital initiatives at NYU Medical Center.
The facility, adjoining the medical school's East River campus, is part of a growth agenda established by the school's dean Robert Glickman in 1998. "We're looking at our research, our educational programs, and our clinical programs, and together ... we are ...
